Fort Worth, TX — Fort Worth, Texas

Fort Worth, TX is a clinical research site located in Fort Worth, Texas, United States 76104.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Fort Worth, TX has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Diabetic Macular Edema (DME), COVID-19.

Sponsors: EyeBiotech Ltd., Renibus Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fort Worth, TX?

Fort Worth, TX has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fort Worth, TX conducted?

Fort Worth, TX has 3 clinical trials on record, with 2 currently active. Their work covers Diabetic Macular Edema (DME), COVID-19.

Is Fort Worth, TX accredited by Crixeo Health?

Fort Worth, TX has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fort Worth, TX?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.